Search results for "Keeping tabs"
Spotlight on cardiovascular risk in type 2 diabetes
The American Heart Association released a scientific statement on managing cardiovascular (CV) risk factors, while recent research focused on CV mortality in patients with diabetes and nonalcoholic fatty liver disease and CV outcomes in high-risk patients who take sodium-glucose cotransporter-2 inhibitors.
https://diabetes.acponline.org/archives/2022/01/14/5.htm
14 Jan 2022
Spotlight on the gut microbiome
A Finnish study found that certain gut bacteria were more common in people who later developed type 2 diabetes, while an Israeli study identified a distinct microbial signature in adults with type 1 diabetes compared with healthy controls.
https://diabetes.acponline.org/archives/2022/02/11/5.htm
11 Feb 2022
Spotlight on exercise
Sports medicine experts updated their recommendations on exercise in type 2 diabetes, while a study found that physical activity was associated with lower dementia risk in patients with new type 2 diabetes, and another found that exercise might be more beneficial in the afternoon than the morning.
https://diabetes.acponline.org/archives/2022/03/11/5.htm
11 Mar 2022
Spotlight on diabetes after COVID-19
A cohort study in U.S. veterans and a retrospective analysis in Germany found higher risk for incident diabetes in patients who had had COVID-19.
https://diabetes.acponline.org/archives/2022/04/08/5.htm
8 Apr 2022
Spotlight on efficacy of SGLT-2 inhibitors and GLP-1 receptor agonists
One recent study compared sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists to each other, a meta-analysis tried to quantify their benefits compared to placebo, and a third study looked at their effects relative to insulin.
https://diabetes.acponline.org/archives/2022/05/13/5.htm
13 May 2022
Spotlight on tirzepatide
The first glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist was approved by the FDA and analyzed by a number of recent studies.
https://diabetes.acponline.org/archives/2022/06/10/5.htm
10 Jun 2022
Spotlight on inpatient hyperglycemia
A new guideline offered recommendations on managing hyperglycemia in hospital patients with or without diabetes. Recent studies looked at the effects of elevated blood glucose levels after surgery and in the ICU.
https://diabetes.acponline.org/archives/2022/07/08/5.htm
8 Jul 2022
Spotlight on older diabetes patients
Recent studies of older patients with diabetes described the effectiveness of a lifestyle intervention, low use of continuous glucose monitoring, and high risk of falls with hypoglycemia.
https://diabetes.acponline.org/archives/2022/08/12/5.htm
12 Aug 2022
Spotlight on innovative uses of CGM
Recent trials indicated effectiveness of open-source automated insulin delivery systems, inpatient insulin management based on continuous glucose monitoring (CGM), and CGM for certain patients with type 2 diabetes who are not taking insulin.
https://diabetes.acponline.org/archives/2022/09/16/5.htm
16 Sep 2022
Spotlight on diabetes drug class comparisons
A large trial compared insulin, a sulfonylurea, a glucagon-like peptide-1 (GLP-1) receptor agonist, and a dipeptidyl peptidase-4 inhibitor as second-line therapy, while a modeling study considered GLP-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors as first-line agents.
https://diabetes.acponline.org/archives/2022/10/14/5.htm
14 Oct 2022